Bristol-Myers Squibb Co - Company Profile
Powered by 
All the sales intelligence you need on Bristol-Myers Squibb Co in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Bristol-Myers Squibb Co fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Bristol-Myers Squibb Co.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
View moreThe following section provides information on Bristol-Myers Squibb Co’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Bristol-Myers Squibb Co's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Christopher S. Boerner, PhD
Chairman; Chief Executive Officer Executive BoardDr. Christopher S. Boerner has been the Chief Executive Officer and Chairman of the company since 2024. Prior to this, he served as the Executive Vice President and Chief Commercialization Officer of the company; President and Head of International Markets of the company; Executive Vice President of Commercial and Senior Vice President of Commercial; Vice President of Marketing at Seattle Genetics; Head of Marketing; and Vice President of Marketing at Dendreon. Dr. Boerner also served as the Director of Marketing on Avastin, Director of Avastin franchise management, and Associate Director of Oncology Market Development.
David V. Elkins
Chief Financial Officer; Executive Vice President Senior ManagementMr. David V. Elkins has been the Executive Vice President and Chief Financial Officer of the company since 2019. Prior to this, he served as the Chief Financial Officer of Celgene. Mr. Elkins also served as the Chief Financial Officer and Vice President of Consumer Products, Medical Development and Corporate Functions, Group Vice President and Chief Financial Officer, Consumer and Consumer Medicines at Johnson & Johnson.
Hiroshi Chris Shibutani, M.D.
Chief Strategy Officer; Executive Vice President Senior ManagementMr. Hiroshi Chris Shibutani has been the Executive Vice President and Chief Strategy Officer of the company since June 2025. Prior to this, he served as the Senior Analyst & Managing Director, Pharmaceuticals and Biotechnology Equity Research at Goldman Sachs. Previously, he served as the Senior Analyst & Managing Director, Biotechnology Equity Research at Cowen Group Inc. Mr. Shibutani also served as the Senior Analyst - Healthcare Equity Research at Pioneer Amundi Investments.
Amanda Poole
Chief People Officer; Executive Vice President Senior ManagementMs. Amanda Poole has been the Executive Vice President and Chief People Officer of the company since 2024. Prior to this, she served as the Senior Vice President, People Strategy, Solutions & Services of the company. Previously, she served as the Senior Vice President and Head of Human Resources of the company. Ms. Poole also served as the Head of Commercialization of the company; Vice President and Head of BMS/Celgene Integration of the company.
Cristian Massacesi, M.D
Chief Medical Officer; Executive Vice President; Head - Development Senior ManagementMr. Cristian Massacesi has been the Executive Vice President, Chief Medical Officer, and Head of Development of the company since August 2025. Prior to this, he served as the Chief Medical Officer of AstraZeneca. Previously, he worked at Pfizer, Alexion, and Novartis.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer